SCHEMBL20749378

SCHEMBL20749378

CCCSNc1cc(F)c(F)c(C(=O)c2ccc3ncc(N4CCOCC4)nc3c2)c1F

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CDK6 Q00534 2/20 0.41
SHMT2 P34897 2/20 0.40
HPGD P15428 1/20 0.39
PIK3CD O00329 5/20 0.39
PIK3CA P42336 5/20 0.39
PIK3CB P42338 5/20 0.39
PIK3CG P48736 5/20 0.39
MTOR P42345 4/20 0.39
PRKDC P78527 1/20 0.39
PIK3C3 Q8NEB9 1/20 0.39
AKT1 P31749 5/20 0.39
HDAC3 O15379 1/20 0.38
HDAC2 Q92769 1/20 0.38
BRAF P15056 1/20 0.37
KCNQ3 O43525 1/20 0.37
KCNQ2 O43526 1/20 0.37
FGFR2 P21802 1/20 0.37
FGFR3 P22607 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18627635 0.92 CDK6 (0.43) CDK6HPGDPIK3CDPIK3CAPIK3CB
SCHEMBL20749392 0.88 CDK6 (0.42) CDK6SHMT2HPGDPIK3CDPIK3CA
SCHEMBL20749358 0.86 CDK6 (0.42) CDK6SHMT2HPGDPIK3CDPIK3CA
SCHEMBL20749385 0.85 ALDH1A1 (0.41) CDK6SHMT2HPGDPIK3CDPIK3CA
SCHEMBL20749370 0.85 HCAR2 (0.41) CDK6HPGDPIK3CDPIK3CAPIK3CB
SCHEMBL20749362 0.85 NPC1 (0.34) HDAC3HDAC2BRAFKCNQ3KCNQ2
Uplarafenib SCHEMBL14716189 0.84 BRAF (0.51) CDK6HPGDPIK3CDPIK3CAPIK3CB
Uplarafenib SCHEMBL29623930 0.84 BRAF (0.51) CDK6HPGDPIK3CDPIK3CAPIK3CB
SCHEMBL29590072 0.83 CDK6 (0.42) CDK6SHMT2HPGDPIK3CDPIK3CA
SCHEMBL14716359 0.83 CDK6 (0.42) CDK6SHMT2HPGDPIK3CDPIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022119905-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS NEUPHARMA, INC (US) 2022-06-09 WO disclosed
EP-2747767-B1 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS NEUPHARMA INC (US) 2019-02-20 EP disclosed